Low‐level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus‐hepatitis C virus coinfection

References

• Alberti A, Pontisso P, Chemello L, Fattovich G, Benvegnu L, Belussi F, et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol 1995;22 Suppl 1:38–41.
   PubMedGoogle Scholar
• Liaw YF. Role of hepatitis C virus in double and triple hepatitis virus infection. Hepatology 1995;22:1101–8.
   PubMed Web of Science ®Google Scholar
• Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YHW. Suppression of hepatitis B virus and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993;67: 5823–32.
   Google Scholar
• Crespo J, Lozano JL, de la Cruz F, Rodrigo L, Rodriguez M, San Miguel G, et al. Prevalence and significance of hepatitis C virus viremia in chronic hepatitis B. Am J Gastroenterol 1994; 89: 1147–51.
   Google Scholar
• Fong TL, DiBisceglie A, Waggoner J, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991;14:64–7.
   Google Scholar
• Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529–33.
   PubMed Web of Science ®Google Scholar
• Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S, et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994;21:158–66.
   Google Scholar
• Chu CM, Yeh CT, Liaw YF. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Microbiol 1998;36:2084–6.
   Google Scholar
• Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C and delta viruses in the termination of hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994;170:358–61.
   PubMed Web of Science ®Google Scholar
• Wang YM, Ng WC, Lo SK. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore. J Gastroenterol 1999;34:481–5.
   Google Scholar
• Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, El Younsi M, et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 2000;7:15–22.
   Google Scholar
• Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 2000;32:1106–10.
   PubMed Web of Science ®Google Scholar
• Ohkawa K, Hayashi N, Yuki N, Hagiwara H, Kato M, Yamamoto K, et al. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994;21:509–14.
   PubMed Web of Science ®Google Scholar
• Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost- Bezeaux F, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998;28:27–33.
   Google Scholar
• Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, et al. Mapping of serotype-specific immunodominant epitopes in the NS4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993;31:1493–503.
   PubMed Web of Science ®Google Scholar
• Ichimura H, Tamura I, Kurimura O, Koda T, Mizui M, Tsuchie H, et al. Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease. J Med Virol 1994;43:212–5.
   PubMedGoogle Scholar
• Zein NN, Rakela J, Persing DH. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin Proc 1995;70:449–52.
   Google Scholar
• Pawlotsky JM, Roudot-Thoraval F, Pellet C, Aumont P, Darthuy F, Remire J, et al. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns. J Clin Microbiol 1995;33:1357–9.
   PubMedGoogle Scholar
• Yoon SK, Park YM, Byun BH, Bae SH, Yang JM, Ahn BM, et al. The relationship between virological characteristics of hepatitis C virus (HCV) and reactivities to the regional specific proteins of HCV. Korean J Intern Med 2000;15:109–16.
   PubMedGoogle Scholar
• Yuki N, Hayashi N, Kasahara A, Hagiwara H, Ohkawa K, Fusamoto H, et al. Hepatitis C virus replication and antibody response toward specific hepatitis C virus proteins. Hepatology 1994;19:1360–5.
   PubMedGoogle Scholar
• Lok AS, Chien D, Choo QL, Chan TM, Chiu EK, Cheng IK, et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and im- munosuppressed patients. Hepatology 1993;18:497–502.
   PubMed Web of Science ®Google Scholar
• Pawlotsky JM, Bastie A, Pellet C, Remire J, Darthuy F, Wolfe L, et al. Significance of indeterminate third-generation hepatitis C recombinant immunoblot assay. J Clin Microbiol 1996;34:80–3.
   PubMed Web of Science ®Google Scholar
• Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991;13:627–31.
   Google Scholar
• Yeh CT, Shyu WC, Sheen IS, Chu CM, Liaw YF. Quantitative assessment of hepatitis C virus RNA by polymerase chain reaction and a digoxigenin detection system: comparison between branched DNA assay. J Virol Methods 1997;65:219–26.
   Google Scholar
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
   PubMed Web of Science ®Google Scholar
• Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995;2:39–45.
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Felaco FM, Filippini P, Scolastico C, Rapicetta M, Stroffolini T, Piccinino F. Multiple hepatitis virus infections in chronic HBsAg carriers in Naples. Arch Virol 1997;142:445–51.
   Google Scholar
• Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology 1998; 45:1206–13.
   PubMedGoogle Scholar
• Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132–7.
   PubMed Web of Science ®Google Scholar
• Milich DR, Jones J, Hughes J, Maruyama T. Role of T-cell tolerance in the persistence of hepatitis B virus infection. J Immunother 1993;14:226–33.
   Google Scholar
• Nakano Y, Kijosawa K, Sodeyawa T, et al. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon. Scand J Gastroenterol 1993;28: 335–42.
   PubMed Web of Science ®Google Scholar
• Yuki N, Hayashi N, Hagiwara H, et al. Changes in antibodies to specific hepatitis C virus antigens with interferon alpha therapy: analysis by recombinant immunoblot assay. Am J Gastroenterol 1993;88:914–8.
   PubMedGoogle Scholar
• Egger D, Wolk B, Gosert R, Bianchi L, Blum HE, Moradpour D, et al. Expression of hepatitis C virus proteins induces distinct membrane alternations including a candidate viral replication complex. J Virol 2002;76:5974–84.
   PubMed Web of Science ®Google Scholar